MRD (minimal/measurable residual disease) testing is changing the way doctors understand and monitor blood cancers. In this episode, we talk with Dr. John Burke of the Rocky Mountain Cancer Center about how MRD testing works, what the results mean to patients and their care teams, and how ongoing clinical research is helping shape more personalized and hopeful approaches to treatment.

CLICK HERE to participate in our episode survey.

Mentioned on this episode:

Minimal/Measurable Residual Disease (MRD) fact sheet
Minimal/Measurable Residual Disease (MRD) chart
CAR T-cell therapy

Additional LLS Support Resources:

Free Nutrition Consultations
Information Specialists
Free telephone/web patient programs
Clinical Trial Support Center
Advocacy and Public Policy
Free booklets
Financial support
Young Adult Resources
Support groups
Survivorship Workbook
Community
Caregiver support
Caregiver Workbook
Mental Health Resources

Supported by Adaptive Biotechnologies Corporation and Allogene Therapeutics.

The post MRD Explained: What it Means for You and Your Care first appeared on The Bloodline with Blood Cancer United Podcast.